Plasma Exchange in Acute-on-Chronic Liver Failure (ACLF): A Bridge to Liver Transplant, Not a Cure
By Dr. Gursagar Singh Sahota (LiverGuru)
Chief Liver Transplant Surgeon, Dayanand Medical College & Hospital, Ludhiana
Acute-on-Chronic Liver Failure (ACLF): A Medical Emergency
Acute-on-Chronic Liver Failure (ACLF) is one of the most life-threatening conditions encountered in liver disease. It occurs when a person with chronic liver disease or cirrhosis experiences a sudden deterioration due to an acute trigger such as infection, alcohol-related hepatitis, hepatitis B reactivation, drug-induced liver injury, gastrointestinal bleeding, or another acute insult.
Unlike stable cirrhosis, ACLF progresses rapidly and can lead to liver failure, kidney failure, brain dysfunction (hepatic encephalopathy), severe infections, circulatory collapse, and failure of multiple organs within days.
Without timely intervention, mortality can be extremely high.
For many patients with severe ACLF, liver transplantation remains the only definitive treatment.
However, transplantation cannot happen immediately. A suitable donor must be identified, evaluated, medically optimized, and prepared for surgery. During this critical waiting period, every day becomes precious.
This is where Therapeutic Plasma Exchange (TPE) can play an important role.
What Is Plasma Exchange?
Therapeutic Plasma Exchange (TPE) is an extracorporeal blood purification therapy.
During the procedure:
- Blood is removed through a special machine.
- The patient's plasma (which contains toxins and inflammatory mediators) is separated.
- The removed plasma is replaced with fresh frozen plasma (FFP), albumin, or a combination depending on the clinical situation.
- The purified blood is then returned to the patient.
The procedure usually lasts 2–4 hours and is performed in specialized intensive care units by experienced multidisciplinary teams.
How Does Plasma Exchange Help in ACLF?
In ACLF, the liver is unable to remove toxins and inflammatory substances from the bloodstream.
This results in:
- Excess bilirubin
- Cytokine storm
- Systemic inflammation
- Coagulopathy
- Progressive organ dysfunction
Therapeutic plasma exchange helps by:
1. Reducing Bilirubin Levels
High bilirubin itself contributes to worsening organ dysfunction.
Plasma exchange can rapidly lower bilirubin, improving the patient's overall metabolic environment.
2. Removing Harmful Inflammatory Cytokines
ACLF is not merely liver failure.
It is also a severe inflammatory syndrome.
TPE removes circulating inflammatory mediators that contribute to:
- Kidney injury
- Brain dysfunction
- Circulatory instability
- Multi-organ failure
3. Correcting Coagulation Abnormalities
Since plasma contains clotting factors, replacing diseased plasma with donor plasma temporarily improves coagulation abnormalities.
This may reduce bleeding risk in selected patients and facilitate invasive procedures when required.
4. Supporting Other Organ Systems
By reducing toxins and inflammation, plasma exchange may temporarily improve:
- Kidney function
- Mental status
- Blood pressure
- Overall physiological stability
These improvements may provide valuable time while definitive treatment is arranged.
The Most Important Message: Plasma Exchange Is NOT a Cure
This is perhaps the biggest misconception among patients and even occasionally among healthcare providers.
Plasma exchange does not regenerate a failing cirrhotic liver.
It does not reverse advanced cirrhosis.
It does not permanently improve liver function.
It does not eliminate the need for liver transplantation in patients who otherwise meet transplant criteria.
Think of plasma exchange as a bridge, not the destination.
It buys valuable time.
It does not replace definitive treatment.
The Bridge to Liver Transplant
One of the greatest advantages of plasma exchange is that it can stabilize carefully selected patients long enough to:
- Identify a suitable living liver donor.
- Complete donor investigations.
- Optimize the donor medically.
- Complete transplant evaluation.
- Treat active infections before surgery.
- Improve organ function sufficiently to undergo major surgery.
Without this bridge, some patients may deteriorate too rapidly before transplantation becomes possible.
A Real-World Example
Consider a 48-year-old gentleman with alcohol-related cirrhosis who develops ACLF following a severe bacterial infection.
He presents with:
- Bilirubin of 32 mg/dL
- INR 3.0
- Hepatic encephalopathy
- Acute kidney injury
- MELD score above 35
His wife volunteers to become a living liver donor.
However, donor evaluation requires several days, including blood tests, CT angiography, liver volumetry, cardiac assessment, and multidisciplinary clearance.
During this period, the patient's condition continues to worsen.
The transplant team initiates therapeutic plasma exchange along with intensive care, antibiotics, renal support, nutritional optimization, and treatment of the underlying infection.
After multiple carefully planned plasma exchange sessions, the patient becomes hemodynamically more stable. Bilirubin decreases, encephalopathy improves, and kidney function stabilizes sufficiently for transplantation.
A successful living donor liver transplant is then performed.
It was not the plasma exchange that cured the patient.
The liver transplant saved his life.
Plasma exchange simply helped him survive long enough to reach transplantation.
This distinction is extremely important.
When Plasma Exchange May Not Be Helpful
Unfortunately, plasma exchange is sometimes overused.
Not every patient with jaundice or liver disease requires repeated plasma exchange.
Repeated procedures without a clear objective may expose patients to:
- High financial burden
- Multiple blood product transfusions
- Allergic reactions
- Catheter-related complications
- Increased infection risk
- Delay in timely referral for liver transplantation
Perhaps most importantly, unnecessary plasma exchange can create a false sense of improvement while valuable time for transplantation is lost.
The decision to perform plasma exchange should always be individualized and made by an experienced liver failure and liver transplant team.
Who Should Be Evaluated for Liver Transplant Instead of Repeated Plasma Exchange?
Patients with cirrhosis should seek early evaluation at a liver transplant centre if they have:
- Persistent jaundice
- Recurrent hepatic encephalopathy
- Recurrent ascites requiring repeated drainage
- Kidney dysfunction
- Gastrointestinal bleeding from varices
- Frequent hospital admissions
- High MELD score
- Acute-on-Chronic Liver Failure
Early referral often improves transplant outcomes.
Waiting until multiple organs fail significantly reduces the chances of successful treatment.
A Comprehensive Approach Matters
Managing ACLF requires far more than plasma exchange.
Successful treatment involves:
- Early identification of the precipitating event
- Aggressive infection control
- Intensive care support
- Kidney replacement therapy when indicated
- Nutritional optimization
- Management of hepatic encephalopathy
- Careful fluid and electrolyte management
- Continuous reassessment for liver transplantation
Plasma exchange is only one component of this comprehensive strategy.
The LiverGuru Philosophy
At LiverGuru, our philosophy is simple:
Treat the patient—not just the laboratory values.
Every patient with ACLF deserves an individualized treatment plan based on:
- The severity of liver disease
- The reversibility of the acute insult
- The degree of organ failure
- The likelihood of native liver recovery
- The urgency of liver transplantation
Our goal is not to perform more procedures.
Our goal is to perform the right intervention at the right time.
Sometimes that means plasma exchange.
Sometimes it means intensive medical management alone.
And in many patients, it means arranging a life-saving liver transplant without unnecessary delay.
Key Takeaways
- Plasma exchange can temporarily improve patients with selected cases of Acute-on-Chronic Liver Failure.
- It helps remove inflammatory mediators, reduce bilirubin, and stabilize organ function.
- It is not a definitive treatment for ACLF.
- It should never delay referral for liver transplant evaluation.
- In carefully selected patients, plasma exchange acts as an important bridge while preparing for liver transplantation.
- Every patient should be assessed by an experienced liver transplant team before undergoing repeated plasma exchange sessions.
Frequently Asked Questions (FAQs)
Can plasma exchange cure liver failure?
No. Plasma exchange temporarily supports the body but cannot replace a damaged liver or reverse advanced cirrhosis.
How many plasma exchange sessions are required?
There is no fixed number. The decision depends on the patient's clinical condition, response to therapy, transplant planning, and underlying cause of ACLF.
Can plasma exchange replace liver transplantation?
No. In patients with irreversible liver failure, liver transplantation remains the only definitive treatment.
Should every ACLF patient receive plasma exchange?
No. Patient selection is critical. Some patients benefit significantly, while others require urgent transplantation or alternative supportive therapies instead.
When should a patient be referred to a liver transplant centre?
As soon as ACLF is diagnosed or when cirrhosis begins to decompensate. Early referral allows timely assessment, donor evaluation, and better outcomes.
Final Message from Dr. Gursagar Singh Sahota
As liver transplant surgeons, one of our greatest responsibilities is knowing when to support the native liver and when to move decisively toward transplantation.
Therapeutic plasma exchange is a valuable tool in modern ACLF management—but only when used for the right patient, at the right time, and for the right reason.
Used judiciously, it can provide the precious time needed to arrange a life-saving liver transplant.
Used indiscriminately, it may only delay definitive treatment.
If you or your loved one has Acute-on-Chronic Liver Failure, seek evaluation at an experienced liver transplant centre early. Timely decisions save lives.